Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered Proteomic Profile of Exosomes Secreted from Vero Cells Infected with Porcine Epidemic Diarrhea Virus. | Viruses | 2023 | 37631983 | PubTator, text mining | PubMed |
| Laser Biostimulation Induces Wound Healing-Promoter β2-Defensin Expression in Human Keratinocytes via Oxidative Stress. | Antioxidants (Basel) | 2023 | 37627545 | PubTator, text mining | PubMed |
| Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. | Front Oncol | 2023 | 37593098 | PubTator, text mining | PubMed |
| Identification of fibroblast-related genes based on single-cell and machine learning to predict the prognosis and endocrine metabolism of pancreatic cancer. | Front Endocrinol (Lausanne) | 2023 | 37588985 | PubTator, text mining | PubMed |
| Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro. | Comput Struct Biotechnol J | 2023 | 37576748 | PubTator, text mining | PubMed |
| Mechanisms and regulation of defensins in host defense. | Signal Transduct Target Ther | 2023 | 37574471 | PubTator, text mining | PubMed |
| Pyronaridine as a Bromodomain-Containing Protein 4-N-Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation. | Molecules | 2023 | 37570684 | PubTator, text mining | PubMed |
| The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth. | Cancers (Basel) | 2023 | 37568667 | PubTator, text mining | PubMed |
| Fragment expansion with NUDELs - poised DNA-encoded libraries. | Chem Sci | 2023 | 37564419 | PubTator, text mining | PubMed |
| Heparanase-A single protein with multiple enzymatic and nonenzymatic functions. | Proteoglycan Res | 2023 | 37547889 | PubTator, text mining | PubMed |
| The role of TGF-β and antimicrobial peptides in basal cell carcinoma: a systematic review. | Postepy Dermatol Alergol | 2023 | 37545828 | PubTator, text mining | PubMed |
| [Polymorphisms associated with dental caries in pediatric populations: a systematic review]. | Rev Med Inst Mex Seguro Soc | 2023 | 37540722 | PubTator, text mining | PubMed |
| Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis. | Front Genet | 2023 | 37533434 | PubTator, text mining | PubMed |
| Knowledge of India as an Instrument of Nazi Politics: Ludwig Alsdorf, German Indology and Indian Anti-Colonialism. | NTM | 2023 | 37532872 | PubTator, text mining | PubMed |
| In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. | Hum Gene (Amst) | 2023 | 37521006 | PubTator, text mining | PubMed |
| Antimicrobial and Defense Proteins in Chronic Rhinosinusitis with Nasal Polyps. | Medicina (Kaunas) | 2023 | 37512070 | PubTator, text mining | PubMed |
| Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study. | Life (Basel) | 2023 | 37511907 | PubTator, text mining | PubMed |
| Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review. | J Pers Med | 2023 | 37511699 | PubTator, text mining | PubMed |
| Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression. | Cancers (Basel) | 2023 | 37509346 | PubTator, text mining | PubMed |
| Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential. | Biomolecules | 2023 | 37509171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=14